Why the study?
Does ergometrine administration reveal a generalized sensitivity to alpha-adrenergic stimulation in patients susceptible to coronary or oesophageal spasm compared to those without?
Does ergometrine administration reveal a generalized sensitivity to alpha-adrenergic stimulation in patients susceptible to coronary or oesophageal spasm compared to those without?
Ergometrine testing suggests that coronary and oesophageal spasms are not driven by a generalized sensitivity to alpha-adrenergic stimulation.
Answers are grounded in this paper and cite their sources.
Ergometrine testing finds no generalized alpha-adrenergic sensitivity in coronary or oesophageal spasm; leaves open distinct mechanisms for targeted study.
Vascular responses to ergometrine were compared in groups of patients subject to coronary artery spasm, or oesophageal spasm, or neither. We measured the degree of diffuse narrowing at different coronary artery sites (not in spasm), and the rise in blood pressure. The data provide no evidence for a generalised sensitivity to alpha-adrenergic stimulation underlying either of these two clinical entities. The left main stem was narrowed significantly less than the three main branches of the coronary artery tree. The degree of diffuse coronary artery narrowing was not influenced by the presence or absence of minor (less than or equal to 50%) fixed stenotic lesions, nor by the initial calibre of the arteries. Ergometrine did not alter arterial lactate concentration or lactate extraction in the absence of coronary spasm.
No takes yet. Share an insight, caveat, or question.
Dalal et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: